Checkmate Pharmaceuticals Inc (CMPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-1991 | 03-1990 | |
| Cash Flows From Operating Activities | ||
| Net Income | 217 | 217 |
| Depreciation Amortization | 2,157 | 2,157 |
| Other Working Capital | -6,319 | -6,319 |
| Other Operating Activity | -469 | -469 |
| Operating Cash Flow | $-4,414 | $-4,414 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -3,194 | -3,194 |
| Investing Cash Flow | $-3,194 | $-3,194 |
| Cash Flows From Financing Activities | ||
| Other Financing Activity | 6,887 | 6,887 |
| Financing Cash Flow | $6,887 | $6,887 |
| Exchange Rate Effect | 35 | 35 |
| Beginning Cash Position | 1,162 | 1,162 |
| End Cash Position | 476 | 476 |
| Net Cash Flow | $-686 | $-686 |
| Free Cash Flow | ||
| Operating Cash Flow | -4,414 | -4,414 |
| Free Cash Flow | -4,414 | -4,414 |